Buffalo BioSciences and ECapital-Financing announced the formation of a joint venture to assist bioscience companies in achieving the “Next Level” through raising capital, optimizing the product's marketing, strategic alliances, and interim management. This new venture is slated to be launched in February 2007.
Our goal is to allow bioscience companies to focus on their challenging technologies, while our joint efforts “focus like a laser” on the business opportunities associated with their unique bioscience product offerings. The bioscience areas that will be focused on are: Stem Cell Biology & Regenerative Medicine, Therapeutics, Molecular Diagnostics, Bio-Manufacturing, Drug Discovery and Medical Devices. Our joint service offering for bioscience companies are:
- Fund Raising
- Senior Level Interim Management
- Turnaround Management Services (strategic divestures, technology licensing, refocusing objectives)
- Market Research driven with industry participants feedback
- Implement the processes to develop a viable theoretical bioscience concept into a successful commercial offering.
"The opportunity to team up with the outstanding resources of Buffalo BioSciences will allow ECapital-Financing to expand our turnaround expertise and business optimization processes into a new challenging industry,” Michael R. Koeppel, Founder of ECapital-Financing, stated. “In addition to the experienced leadership team of Buffalo BioSciences, this proven company has the network and infrastructure in place to allow us to launch this venture into a productive endeavor immediately."
Eric Cornavaca, Partner at Buffalo BioSciences, added “this is an excellent opportunity for our firm to unite the proven business acumen of ECapital-Financing with our bioscience expertise. ECapital-Financing's strong track record in raising capital for businesses is a critical need of our customers. This aspect places us head and shoulders above the competition.”